Immunic, Inc. Common Stock (IMUX) is a publicly traded Healthcare sector company. As of October 17, 2026, IMUX trades at $7.02 with a market cap of $96.88M and a P/E ratio of -11.90. IMUX moved -2.39% today. Year to date, IMUX is +9.38%; over the trailing twelve months it is -14.57%. Its 52-week range spans $5.06 to $17.43. Analyst consensus is strong buy with an average price target of $37.38. Rallies surfaces IMUX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for IMUX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $7.02 |
| Market Cap | $96.88M |
| P/E Ratio | -11.90 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.43 |
| 52-Week Low | $5.06 |
| Volume | 342.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-97.17M |
| Gross Margin | 0.00% |
10 analysts cover IMUX: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $37.38.